This Acute Myeloid Leukemia infographic offers a snapshot of the real-world patient insights collected by our Therapy Watch study, based on data collected from a panel of 220 physicians across 7 EU markets. A 2024 study update is planned to track the market evolution.
Jump to a slide with the slide dots.
Our client marketed Product X for chronic myeloid leukemia (CML) which had been submitted for first-line indication.
Read moreTania Rodrigues investigates the market access and commercialization potential for manufacturers of CAR-T therapies.
Read moreRapport is our monthly newsletter where we share our latest expertise and experience.